IRIX - IRIDEX CORP
vs
Region: US
Website: iridex.com
Employees: 120
IPO year: 1996
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name in 1995.
IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic Investments and Revenue Growth ...
IRIDEX Corp (IRIX) reports positive EBITDA and revenue growth, driven by strategic investments and cost reduction, despite facing liquidity and operational challenges.
Read moreIridex: Q4 Earnings Snapshot
MOUNTAIN VIEW, Calif. AP) — Iridex Corp. IRIX) on Thursday reported a loss of $834,000 in its fourth quarter.
Read moreIridex Reports Fourth Quarter and Full Year 2024 Financial Results
MOUNTAIN VIEW, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the fourth quarter and full year ended December 28, 2024. Fourth Quarter 2024 Results & Recent Highlights Achieved positive adjusted EBITDA in the fourth quarter of 2024Successfully implemented pr
Read more